CRT 2026
Coronary
David Cox, MD, MSCAI
Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States
Disclosure(s): No financial relationships to disclose
Rony Lahoud, MD
Associate Professor
University of Vermont
S. Burlington, Vermont, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ablative Solutions, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Mazen S. Abu-Fadel, MD, MBA
Interventional Cardiology
Oklahoma Heart Hospital
Edmond, Oklahoma, United States
Disclosure(s): No financial relationships to disclose
Lindsey Cilia, MD
Co-Director of Complex Coronary Therapeutics Program
Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States
Disclosure(s): No financial relationships to disclose
Ali Denktas, MD, FACC, FSCAI
Professor of Medicine/ Director, Cardiac Catheterization Laboratories
Baylor College of Medicine
Houston, Texas, United States
Disclosure(s): No financial relationships to disclose
Suhail Dohad, MD
Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
Cedars Sinai Medical Center
Beverly Hills, California, United States
Disclosure(s): No financial relationships to disclose
Edo Kaluski, MD, FACC, FESC, FSCAI
Director of Cath Lab & Interventional Cardiology
Robert Packer Hospital Guthrie Health Systems
Sayre, Pennsylvania, United States
Disclosure(s): No financial relationships to disclose
Michael Mahmoudi, MD
Professor of Interventional Cardiology
University Hospital Southampton NHS FT
Southampton, England, United Kingdom
Disclosure(s): No financial relationships to disclose